Literature DB >> 14751003

Dopamine and semantic activation: an investigation of masked direct and indirect priming.

Anthony J Angwin1, Helen J Chenery, David A Copland, Wendy L Arnott, Bruce E Murdoch, Peter A Silburn.   

Abstract

To investigate the effects of dopamine on the dynamics of semantic activation, 39 healthy volunteers were randomly assigned to ingest either a placebo (n = 24) or a levodopa (n = 16) capsule. Participants then performed a lexical decision task that implemented a masked priming paradigm. Direct and indirect semantic priming was measured across stimulus onset asynchronies (SOAs) of 250, 500 and 1200 ms. The results revealed significant direct and indirect semantic priming effects for the placebo group at SOAs of 250 ms and 500 ms, but no significant direct or indirect priming effects at the 1200 ms SOA. In contrast, the levodopa group showed significant direct and indirect semantic priming effects at the 250 ms SOA, while no significant direct or indirect priming effects were evident at the SOAs of 500 ms or 1200 ms. These results suggest that dopamine has a role in modulating both automatic and attentional aspects of semantic activation according to a specific time course. The implications of these results for current theories of dopaminergic modulation of semantic activation are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751003     DOI: 10.1017/S1355617704101033

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  15 in total

1.  Functional connectivity in an fMRI study of semantic and phonological processes and the effect of L-Dopa.

Authors:  Madalina E Tivarus; Ashleigh Hillier; Petra Schmalbrock; David Q Beversdorf
Journal:  Brain Lang       Date:  2007-04-06       Impact factor: 2.381

2.  L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study.

Authors:  Clare Kelly; Greig de Zubicaray; Adriana Di Martino; David A Copland; Philip T Reiss; Donald F Klein; F Xavier Castellanos; Michael P Milham; Katie McMahon
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

3.  Dopaminergic modulation of semantic priming in Parkinson disease.

Authors:  Andrew S Pederzolli; Madalina E Tivarus; Punit Agrawal; Sandra K Kostyk; Karen M Thomas; David Q Beversdorf
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

4.  Effects of dopaminergic modulation on automatic semantic priming: a double-blind study.

Authors:  Christina Andreou; Kristina Veith; Vasilis P Bozikas; Tania M Lincoln; Steffen Moritz
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

5.  Semantic memory in schizophrenia: association with cell membrane essential fatty acids.

Authors:  Ruth Condray; Jeffrey K Yao; Stuart R Steinhauer; Daniel P van Kammen; Ravinder D Reddy; Lisa A Morrow
Journal:  Schizophr Res       Date:  2008-10-16       Impact factor: 4.939

6.  Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study.

Authors:  Christina Andreou; Steffen Moritz; Kristina Veith; Ruth Veckenstedt; Dieter Naber
Journal:  Schizophr Bull       Date:  2013-05-09       Impact factor: 9.306

7.  Intact encoding, impaired consolidation in procedural learning in Parkinson's disease.

Authors:  Henri Cohen; Emmanuelle Pourcher
Journal:  Exp Brain Res       Date:  2007-02-06       Impact factor: 2.064

8.  The influence of dopamine on automatic and controlled semantic activation in Parkinson's disease.

Authors:  Wendy L Arnott; David A Copland; Helen J Chenery; Bruce E Murdoch; Peter A Silburn; Anthony J Angwin
Journal:  Parkinsons Dis       Date:  2011-11-02

9.  An investigation of semantic similarity judgments about action and non-action verbs in Parkinson's disease: implications for the Embodied Cognition Framework.

Authors:  David Kemmerer; Luke Miller; Megan K Macpherson; Jessica Huber; Daniel Tranel
Journal:  Front Hum Neurosci       Date:  2013-04-18       Impact factor: 3.169

10.  Assaying the effect of levodopa on the evaluation of risk in healthy humans.

Authors:  Mkael Symmonds; Nicholas D Wright; Elizabeth Fagan; Raymond J Dolan
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.